{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:02:41Z","timestamp":1789851761262,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jmii.2026.09.007","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:03:52Z","timestamp":1789398232000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond seropositivity: SARS-CoV-2 IgG responses in high-risk COVID-19 patients"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3421-9223","authenticated-orcid":false,"given":"Matteo Domenico","family":"Marsiglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8640-844X","authenticated-orcid":false,"given":"Roberta","family":"Rovito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Colzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Mari\u00ebn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1893-0455","authenticated-orcid":false,"given":"Elisa","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Tincati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1365-9408","authenticated-orcid":false,"given":"Silvia","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2026.09.007_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069761","article-title":"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study","volume":"376","author":"Lauring","year":"2022","journal-title":"The BMJ"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib2","article-title":"Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY","volume":"20","author":"Green","year":"2022","journal-title":"BMC Med"},{"issue":"16","key":"10.1016\/j.jmii.2026.09.007_bib3","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 Vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36561-6","article-title":"Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies","volume":"14","author":"Planas","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmii.2026.09.007_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20032150","article-title":"Outcomes of elderly patients hospitalized with the SARS-CoV-2 Omicron B.1.1.529 variant: a systematic review","volume":"20","author":"Fericean","year":"2023","journal-title":"Int J Environ Res Publ Health"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-09633-1","article-title":"Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications","volume":"24","author":"Nakamura","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib7","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-53727-y","article-title":"Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial","volume":"15","author":"Carpp","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.jmii.2026.09.007_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36561-6","article-title":"Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies","volume":"14","author":"Planas","year":"2023","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.jmii.2026.09.007_bib11","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (Tixagevimab\u2013Cilgavimab) for prevention of Covid-19","volume":"386","author":"Levin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2026.09.007_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.112911","article-title":"SARS-CoV-2 reinfections: overview of efficacy and duration of natural and hybrid immunity","volume":"209","author":"Pilz","year":"2022","journal-title":"Environ Res"},{"key":"10.1016\/j.jmii.2026.09.007_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964525","article-title":"Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity","volume":"13","author":"S\u00f8raas","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-025-00832-8","article-title":"Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms","volume":"5","author":"Rovito","year":"2025","journal-title":"Commun Med"},{"issue":"4 April","key":"10.1016\/j.jmii.2026.09.007_bib15","article-title":"Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients","volume":"20","author":"Marsiglia","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.11.029","article-title":"Functional SARS-CoV-2-Specific immune memory persists after mild COVID-19","volume":"184","author":"Rodda","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.jmii.2026.09.007_bib17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A SARS-CoV-2 surrogate virus neutralisation test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jmii.2026.09.007_bib18","series-title":"R: a Language and environment for statistical computing","year":"2024"},{"key":"10.1016\/j.jmii.2026.09.007_bib19","series-title":"Mucosal immunology","first-page":"1170","article-title":"Role of the humoral immune response during COVID-19: guilty or not guilty? Vol. 15","author":"Yaugel-Novoa","year":"2022"},{"issue":"6","key":"10.1016\/j.jmii.2026.09.007_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.jmii.2026.09.007_bib21","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7898","key":"10.1016\/j.jmii.2026.09.007_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralisation","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"issue":"7948","key":"10.1016\/j.jmii.2026.09.007_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-022-05644-7","article-title":"Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution","volume":"614","author":"Cao","year":"2023","journal-title":"Nature"},{"issue":"7898","key":"10.1016\/j.jmii.2026.09.007_bib24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralisation","volume":"602","author":"Cele","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-024-00948-3","article-title":"Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy","volume":"9","author":"Li","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"7870","key":"10.1016\/j.jmii.2026.09.007_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jmii.2026.09.007_bib27","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jinf.2022.01.044","article-title":"Antibody titres and breakthrough infections with Omicron SARS-CoV-2","volume":"84","author":"Dimeglio","year":"2022","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23923-1","article-title":"Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients","volume":"12","author":"Rovito","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03398-0","article-title":"Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19","volume":"24","author":"Bermejo-Martin","year":"2020","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.jmii.2026.09.007_bib30","doi-asserted-by":"crossref","first-page":"E291","DOI":"10.1093\/cid\/ciaa1054","article-title":"High frequency of SARS-CoV-2 RNAemia and Association with severe disease","volume":"72","author":"Hogan","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jmii.2026.09.007_bib31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jmv.25715","article-title":"Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses","volume":"92","author":"Gorse","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2026.09.007_bib32","first-page":"203","article-title":"Age-related peculiarities of antibody-mediated humoral immune response following SARS-CoV-2 infection","author":"Movsisyan","year":"2025","journal-title":"Exp Gerontol"},{"issue":"3","key":"10.1016\/j.jmii.2026.09.007_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jamda.2021.12.001","article-title":"Previous SARS-CoV-2 infection, Age, and frailty are associated with 6-Month vaccine-induced anti-spike antibody titre in nursing home residents","volume":"23","author":"Dyer","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jmii.2026.09.007_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s43587-021-00114-7","article-title":"SARS-CoV-2, COVID-19 and the aging immune system","volume":"1","author":"Bartleson","year":"2021","journal-title":"Nat Aging"},{"issue":"5","key":"10.1016\/j.jmii.2026.09.007_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16349","article-title":"Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups","volume":"9","author":"Das","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jmii.2026.09.007_bib36","first-page":"13","article-title":"The effect of Age, gender and comorbidities upon SARS-CoV-2 spike antibody induction after two doses of Sinopharm vaccine and the effect of a Pfizer\/BioNtech booster vaccine","author":"Farid","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jmii.2026.09.007_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27797-1","article-title":"Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome","volume":"13","author":"Cervia","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jmii.2026.09.007_bib38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","article-title":"Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2","volume":"25","author":"Yin","year":"2024","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.jmii.2026.09.007_bib39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jmii.2026.09.007_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40291-025-00792-8","article-title":"Advances in understanding long COVID: pathophysiological mechanisms and the role of omics technologies in biomarker identification","volume":"29","author":"da Silva","year":"2025","journal-title":"Mol Diagn Ther Adis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226001234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226001234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:18:39Z","timestamp":1789849119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118226001234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["S1684118226001234"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2026.09.007","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond seropositivity: SARS-CoV-2 IgG responses in high-risk COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2026.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}